A category of musculoskeletal disorders of our joints, muscles, bones, ligaments, tendons and spine are on the rise and a new forecast is as many as 1060 million people -- up from 464 million -- will be living with related disabilities by 2050, placing even greater pressure on stretched healthcare systems.
Published in the latest edition of Lancet Rheumatology, the Global Burden of Disease research was funded by the Bill and Melinda Gates Foundation and used population, health and insurance claims data across 204 countries and territories to measure the prevalence, years of life lived with disability and population data to identify the 2050 projection.
"We highlight there is a substantial burden of what are categorised as 'other' musculoskeletal disorders that would otherwise go unrecognised," says joint first author Manasi Murthy Mittinty, Flinders University College of Medicine and Public Health Senior Lecturer and Harvard Medical School Advanced Global Clinical Scholar Research Fellow.
"The research team has identified that musculoskeletal disorders of the types studied in this research, which excludes osteoarthritis, rheumatoid arthritis, gout, low back pain and neck pain, are a large and growing source of disability in the world that requires public policy consideration," she says.
"We based our forecast on population projections and ageing demographics, indicating that not only are the number of people worldwide living with other musculoskeletal conditions such as systemic lupus erythematosus and spondylopathies increasing but so will be their healthcare needs in 2050 and beyond."
The research team identified:
Dr Mittinty says the research found musculoskeletal disorders globally are reported higher in females, increase overall with age and peak at 60-69 years.
"We have forecast the 494 million cases in 2020 is projected to grow substantially to reach 1060 million people living with other musculoskeletal disabilities by 2050.
"A factor which may add to the projection of course is the emergence of post-COVID-19 implications where a growing cohort of related conditions characterised by musculoskeletal symptoms and loss of mobility are recognised, adding further pressure on health systems and communities."
Co-lead author with Dr Mittinty is Dr Tiffany Gill, from the University of Adelaide Medical School.
Cite This Page: